- Home
- DRIO vs LSTA Comparison
DRIO vs LSTA Comparison
Compare DRIO & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRIO
- LSTA
- Stock Information
- Founded
- DRIO 2011
- LSTA 1980
- Country
- DRIO United States
- LSTA United States
- Employees
- DRIO N/A
- LSTA N/A
- Industry
- DRIO Medical/Dental Instruments
- LSTA Misc Health and Biotechnology Services
- Sector
- DRIO Health Care
- LSTA Health Care
- Exchange
- DRIO Nasdaq
- LSTA Nasdaq
- Market Cap
- DRIO 28.3M
- LSTA 20.0M
- IPO Year
- DRIO N/A
- LSTA N/A
- Fundamental
- Price
- DRIO $0.72
- LSTA $2.61
- Analyst Decision
- DRIO Strong Buy
- LSTA Strong Buy
- Analyst Count
- DRIO 2
- LSTA 1
- Target Price
- DRIO $2.50
- LSTA $15.00
- AVG Volume (30 Days)
- DRIO 157.7K
- LSTA 15.4K
- Earning Date
- DRIO 05-14-2025
- LSTA 05-08-2025
- Dividend Yield
- DRIO N/A
- LSTA N/A
- EPS Growth
- DRIO N/A
- LSTA N/A
- EPS
- DRIO N/A
- LSTA N/A
- Revenue
- DRIO $28,034,000.00
- LSTA $1,000,000.00
- Revenue This Year
- DRIO $16.54
- LSTA N/A
- Revenue Next Year
- DRIO $21.93
- LSTA N/A
- P/E Ratio
- DRIO N/A
- LSTA N/A
- Revenue Growth
- DRIO 47.20
- LSTA N/A
- 52 Week Low
- DRIO $0.50
- LSTA $1.87
- 52 Week High
- DRIO $1.57
- LSTA $4.20
- Technical
- Relative Strength Index (RSI)
- DRIO 52.54
- LSTA 56.77
- Support Level
- DRIO $0.63
- LSTA $2.43
- Resistance Level
- DRIO $0.74
- LSTA $2.78
- Average True Range (ATR)
- DRIO 0.05
- LSTA 0.22
- MACD
- DRIO 0.00
- LSTA 0.02
- Stochastic Oscillator
- DRIO 56.73
- LSTA 67.54
About DRIO DarioHealth Corp.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.